Cerner CERN releases its next round of earnings this Thursday, October 27, 2011. Get the latest predictions in Benzinga's essential guide to the company's third quarter earnings report.
Earnings and Revenue:
Here's how the company's reported EPS has stacked up against analyst estimates in the past:
Quarter | Q2 | Q1 | Q4 | Q3 |
EPS Estimate | $0.41 | $0.36 | $0.40 | $0.35 |
EPS Actual | $0.42 | $0.38 | $0.41 | $0.35 |
Stock Performance:
- Long-term shareholders are already enjoying 12-month gains prior to the announcement
Average Stock Rating:
Competitors:
- CareFusion CFN: Hold with a $0.52 recent quarter EPS
- Computer CSC: Hold with a $0.64 recent quarter EPS
- McKesson MCK: Moderate Buy with a $1.27 recent quarter EPS
- Allscripts MDRX: Moderate Buy with a $0.19 recent quarter EPS
The medical information systems company's industry has seen price/earnings growth of 1.9% during the current fiscal year.
Finally, a description of the company's main areas of operation: Cerner Corporation designs and supports healthcare devices, healthcare information technology, and content solutions for organizations and consumers.
Take Action:
There is your peek into Cerner's upcoming earnings numbers, including some competitors to watch around the time of the announcement. Check back in with us after the announcement for a full recap. In the meantime, here are some links to explore today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.